Does ENASIDENIB Cause Transaminases increased? 6 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Transaminases increased have been filed in association with ENASIDENIB (Idhifa). This represents 0.2% of all adverse event reports for ENASIDENIB.
6
Reports of Transaminases increased with ENASIDENIB
0.2%
of all ENASIDENIB reports
1
Deaths
0
Hospitalizations
How Dangerous Is Transaminases increased From ENASIDENIB?
Of the 6 reports, 1 (16.7%) resulted in death.
Is Transaminases increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENASIDENIB. However, 6 reports have been filed with the FAERS database.
What Other Side Effects Does ENASIDENIB Cause?
Death (650)
Off label use (213)
Fatigue (202)
Nausea (197)
Acute myeloid leukaemia (163)
Hospitalisation (149)
Diarrhoea (144)
Decreased appetite (122)
Platelet count decreased (113)
Drug ineffective (108)
What Other Drugs Cause Transaminases increased?
METHOTREXATE (1,236)
ACETAMINOPHEN (929)
ATORVASTATIN (472)
RITUXIMAB (448)
CYCLOPHOSPHAMIDE (401)
PREDNISONE (362)
ADALIMUMAB (340)
PACLITAXEL (333)
ROSUVASTATIN (324)
CARBOPLATIN (319)
Which ENASIDENIB Alternatives Have Lower Transaminases increased Risk?
ENASIDENIB vs ENBREL
ENASIDENIB vs ENCORAFENIB
ENASIDENIB vs ENDOXAN
ENASIDENIB vs ENDOXAN BAXTER
ENASIDENIB vs ENDOXAN INJ